Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × tislelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 31 Colorectal Neoplasms 18 Stomach Neoplasms 14 Carcinoma, Hepatocellular 12 Neoplasm Metastasis 9 Esophageal Squamous Cell Carcinoma 9 Advanced Solid Tumor 9 Squamous Cell Carcinoma of Head and Neck 8 Lung Neoplasms 7 Head and Neck Neoplasms 7 Esophageal Neoplasms 7 Solid Tumor 4 Neoplasms 4 Melanoma 4 Colonic Neoplasms 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Lymphoma 3 Carcinoma, Renal Cell 3 Biliary Tract Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Locally Advanced Rectal Cancer 2

Interventions

Gemcitabine 17 Mitomycin 9 Docetaxel 6 erdafitinib 5 dodecyl maltoside 4 Cystoscopy 4 BCG Vaccine 4 durvalumab 2 Radiotherapy 2 ALT-803 2 5-aminolevulinic acid hexyl ester 2 viscum album peptide 1 toripalimab 1 pirarubicin 1 pemigatinib 1 monalizumab 1 hydroxycamptothecinum 1 enfortumab vedotin 1 bicalutamide 1 Urine Specimen Collection 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Patient Discharge 1 Paclitaxel 1 Nonsteroidal Anti-Androgens 1 Mitozytrex 1 Maintenance 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡